Clinical Trial Update: Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

View source ↗

Summary

A completed real-world study evaluating the efficacy and safety of Macugen (pegaptanib) for neovascular age-related macular degeneration in routine clinical pra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Neovascular Age-related Macular Degeneration | Status: COMPLETED | Results posted: 2012-04-11